Infinity Power
Infinity Power is a renewable energy company that offers solar, battery storage, and grid infrastructure solutions.
Infinity Power is a renewable energy company that offers solar, battery storage, and grid infrastructure solutions.
Infinity Power has raised $193M across 2 rounds. Its most recent round was a Private Equity of $40.0M in Nov 2025. Full funding history, investors, and team are detailed below.
Funding history
2 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Infinity Power is featured in
Similar companies
GBM works develops conventional methods and techniques for installing offshore wind turbine foundations.
Water Horizon is an energy-tech company that offers innovative renewable energy solutions for industrial heating and cooling applications.
Strataphy offers geothermal cooling via a service model for buildings, industry, data centers, and aquaculture.
Solution Energy offers sustainable, high-capacity power solutions by transforming geothermal energy.
Good Heat offers a clean, on-demand option that is scalable, low-risk, and cost-effective.
Nina Energy is an expert in creating and implementing thermochemical conversion systems for biomass waste.
HySun is a Spanish technology firm focused on green hydrogen.
XL Batteries develops a technology platform to reduce waste formation.
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. Gene therapy offers the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration. Our first product, Glybera, was approved by the European Commission in October 2012 under exceptional circumstances for the treatment of a subset of patients with lipoprotein lipase deficiency, or LPLD, a potentially life-threatening, orphan metabolic disease. We are also developing a pipeline of additional adeno-associated virus (AAV)-based gene therapies through multiple collaborations. We develop our gene therapies using our innovative, modular technology platform, including our proprietary manufacturing process. We initially are focused on orphan diseases but believe that we will also be able to develop gene therapies targeting chronic and degenerative diseases that affect larger populations.
Droppie is a recycling company that makes recycling easy and more accessible for consumers. The app is designed to help consumers recycle more effectively by offering small rewards for their recycled materials.
Schunk Xycarb Technology develops and manufactures high-tech quartz, ceramic, and graphite consumable parts utilized in semiconductor wafer processing equipment. The company provides specialized engineering and coating services to help global chipmakers optimize performance during advanced manufacturing processes.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.